Response to Office Action

BT

MyFonts Inc.

Response to Office Action

PTO Form 1957 (Rev 9/2005)
OMB No. 0651-0050 (Exp. 07/31/2017)

Response to Office Action


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 86136524
LAW OFFICE ASSIGNED LAW OFFICE 104
MARK SECTION
MARK http://uspto.report/TM/86136524/mark.png
LITERAL ELEMENT BT
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size or color.
ARGUMENT(S)

The Examiner has refused registration because she believes that the specimen does not show the applied-for mark. Specifically the Examiner argues that the specimen shows the mark as “CHARTER BT” or “HOMBRE BT” but the drawing submitted with the application is for the mark “BT”.

 

In cases where two or more words may comprise a composite mark, the question of whether one element may be separable depends “if that element presents, or will present, a separate and distinct commercial impression apart from any other matter with which the mark is or will be used on the specimen.” TMEP §807.12(d).

 

Applicant, formerly known as Bitstream Inc., uses BT as an umbrella brand name. “CHARTER,” “HOMBRE” and “AMBIANCE” (also shown in the specimen as filed) are individual font brand names.  It is not uncommon for a trademark owner to use two or more trademarks on packaging, presentations, brochures or other uses in commerce that are deemed acceptable specimens of use. An applicant has latitude in selecting the mark it wants to register. TMEP §807.12(d). The mere fact that two or more elements form a mark does not mean the elements are inseparable for purposes of registration.  TMEP §807.12(d).

 

As shown in the submitted specimens, Applicant uses one mark, BT, to distinguish the font foundry and uses other marks (e.g. CHARTER, HOMBRE or AMBIANCE) to distinguish the specific typeface.  These two marks are used in conjunction with one another while retaining their separate and distinct commercial impressions. See In re Royal BodyCare Inc., 83 USPQ2d 1564 (TTAB 2007) (Board reversed refusal to register term NANOCEUTICAL finding the term actually used in a manner that creates a commercial impression separate and apart from the house mark or trade name RBC’S); see also In re Raychem Corp., 12 USPQ2d 1299 (1989) (Board reversed refusal for the mark TINEL-LOCK where specimen showed TRO6AI-TINEL-LOCK-RING).

 

For the foregoing reasons, Applicant respectfully requests that the Examining Attorney accept the specimen previously submitted with this application as evidence of use of the BT mark in commerce.

SIGNATURE SECTION
RESPONSE SIGNATURE /debra serota/
SIGNATORY'S NAME Debra Serota
SIGNATORY'S POSITION /attorney of record/
DATE SIGNED 05/08/2014
AUTHORIZED SIGNATORY YES
FILING INFORMATION SECTION
SUBMIT DATE Thu May 08 10:33:54 EDT 2014
TEAS STAMP USPTO/ROA-XX.XXX.XX.XX-20
140508103354295714-861365
24-500284515803d79524e56b
d21476ba47b7e3c756397642f
b641aa3ebe27e97eca-N/A-N/
A-20140508102534078953



PTO Form 1957 (Rev 9/2005)
OMB No. 0651-0050 (Exp. 07/31/2017)

Response to Office Action


To the Commissioner for Trademarks:

Application serial no. 86136524 BT(Standard Characters, see http://uspto.report/TM/86136524/mark.png) has been amended as follows:

ARGUMENT(S)
In response to the substantive refusal(s), please note the following:

The Examiner has refused registration because she believes that the specimen does not show the applied-for mark. Specifically the Examiner argues that the specimen shows the mark as “CHARTER BT” or “HOMBRE BT” but the drawing submitted with the application is for the mark “BT”.

 

In cases where two or more words may comprise a composite mark, the question of whether one element may be separable depends “if that element presents, or will present, a separate and distinct commercial impression apart from any other matter with which the mark is or will be used on the specimen.” TMEP §807.12(d).

 

Applicant, formerly known as Bitstream Inc., uses BT as an umbrella brand name. “CHARTER,” “HOMBRE” and “AMBIANCE” (also shown in the specimen as filed) are individual font brand names.  It is not uncommon for a trademark owner to use two or more trademarks on packaging, presentations, brochures or other uses in commerce that are deemed acceptable specimens of use. An applicant has latitude in selecting the mark it wants to register. TMEP §807.12(d). The mere fact that two or more elements form a mark does not mean the elements are inseparable for purposes of registration.  TMEP §807.12(d).

 

As shown in the submitted specimens, Applicant uses one mark, BT, to distinguish the font foundry and uses other marks (e.g. CHARTER, HOMBRE or AMBIANCE) to distinguish the specific typeface.  These two marks are used in conjunction with one another while retaining their separate and distinct commercial impressions. See In re Royal BodyCare Inc., 83 USPQ2d 1564 (TTAB 2007) (Board reversed refusal to register term NANOCEUTICAL finding the term actually used in a manner that creates a commercial impression separate and apart from the house mark or trade name RBC’S); see also In re Raychem Corp., 12 USPQ2d 1299 (1989) (Board reversed refusal for the mark TINEL-LOCK where specimen showed TRO6AI-TINEL-LOCK-RING).

 

For the foregoing reasons, Applicant respectfully requests that the Examining Attorney accept the specimen previously submitted with this application as evidence of use of the BT mark in commerce.



SIGNATURE(S)
Response Signature
Signature: /debra serota/     Date: 05/08/2014
Signatory's Name: Debra Serota
Signatory's Position: /attorney of record/

The signatory has confirmed that he/she is an attorney who is a member in good standing of the bar of the highest court of a U.S. state, which includes the District of Columbia, Puerto Rico, and other federal territories and possessions; and he/she is currently the applicant's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S. attorney or a Canadian attorney/agent not currently associated with his/her company/firm previously represented the applicant in this matter: (1) the applicant has filed or is concurrently filing a signed revocation of or substitute power of attorney with the USPTO; (2) the USPTO has granted the request of the prior representative to withdraw; (3) the applicant has filed a power of attorney appointing him/her in this matter; or (4) the applicant's appointed U.S. attorney or Canadian attorney/agent has filed a power of attorney appointing him/her as an associate attorney in this matter.

        
Serial Number: 86136524
Internet Transmission Date: Thu May 08 10:33:54 EDT 2014
TEAS Stamp: USPTO/ROA-XX.XXX.XX.XX-20140508103354295
714-86136524-500284515803d79524e56bd2147
6ba47b7e3c756397642fb641aa3ebe27e97eca-N
/A-N/A-20140508102534078953



uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed